# The Innovative Devices Access Pathway (IDAP)

Source: https://www.keypedia.com/records/uk_mhra_guidance/uk-mhra/e3e568e2-e72e-4080-9449-6ed72f0d7ee9
Type: Guidance
Published: September 18, 2023
Updated: April 30, 2026

> The Innovative Devices Access Pathway (IDAP) pilot is a strategic initiative launched by the UK Medicines and Healthcare products Regulatory Agency (MHRA) in collaboration with the National Health Service (NHS). Its primary goal is to accelerate the delivery of transformative medical technologies to patients, specifically targeting clinical needs that are currently unmet. By providing a streamlined and integrated regulatory framework, IDAP offers developers a clearer route to market through enhanced support and multi-agency guidance. While the specific names of the eight successful participating companies and their inspection dates were not disclosed in this summary, these selected applicants will receive dedicated assistance from IDAP partners throughout various stages of their product development. The pilot serves as a trial to test the core components of the pathway, gathering feedback to refine the process for future participants. The regulatory framework emphasizes proactive engagement rather than standard enforcement. Required actions for the involved developers include active participation in the pilot stages to provide the necessary data and learning experiences that will shape the permanent IDAP structure. This initiative marks a significant effort to foster innovation while ensuring safety and efficacy within the UK healthcare system.

---

## Content

The Innovative Devices Access Pathway ( IDAP ) pilot is an initiative to bring new technologies and solutions to the National Health Service ( NHS ) to help with medical needs that are not currently being met. The aim of IDAP is to enable and improve patient access to innovative and transformative medical devices by providing an integrated and enhanced regulatory and access pathway to developers. The aim of the pilot is to test the main elements of the pathway and to provide informative learning and feedback that helps to build the future IDAP . The eight successful applicants whose products have been selected for the pilot will receive support at key stages of their product development journey from the IDAP partners.

## Attachments

- [The IDAP Unmet Clinical Need Authorisation (UCNA)](/government/publications/the-innovative-devices-access-pathway-idap/the-idap-unmet-clinical-need-authorisation-ucna)
- [IDAP pilot application guidance (now closed)](/government/publications/the-innovative-devices-access-pathway-idap/idap-pilot-application-guidance)
- [The Innovative Devices Access Pathway (IDAP) - pilot phase (now closed)](/government/publications/the-innovative-devices-access-pathway-idap/the-innovative-devices-access-pathway-idap-pilot-phase)
- [IDAP Data Protection and Privacy information](https://assets.publishing.service.gov.uk/media/65e07e392f2b3b00117cd776/IDAP_Data_Protection_and_Privacy_Information.pdf)
- [Patient and public involvement and engagement in IDAP (now closed) ](/government/publications/the-innovative-devices-access-pathway-idap/patient-and-public-involvement-and-engagement-in-idap)